Clinical Trial Update: Glucose Optimisation With Angiotensin II Antagonist Losartan (GOAAL) [Phase 4]

View source ↗

Summary

Phase 4 trial update on losartan for glucose optimization in hypertension has completed. The GOAAL study was sponsored by Ullevaal University Hospital.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Losartan (losartan)

Snippet

Sponsor: Ullevaal University Hospital | Conditions: Hypertension | Phase 4 | Status: COMPLETED